Home LiteratureArticle Details
PMID: 6993700 Published · ppublish English Journal Article

Proteinuria during long-term captopril therapy.

JAMA ·Vol. 244 ·No. 4 ·1980-07-25 ·Pages 346-9

Case DB, Atlas SA, Mouradian JA, Fishman RA, Sherman RL, Laragh JH

Abstract

Proteinuria developed in six of 81 hypertensive patients given captopril for at least four months (protein excretion, greater than 200 mg/24 hr). Two had previously elevated protein excretion. In all patients the increased protein excretion occurred by the fourth month of treatment. It subsided in four after two to nine months, despite continued therapy. In two of the four, proteinuria cleared completely within seven months after onset, while in the other two it subsided to the range of 600 mg/24 hr. However, in the remaining two patients proteinuria persisted during captopril therapy and was associated with hypoalbuminemia and hypercholesterolemia. Renal biopsy specimens showed mild membranous nephropathy in two patients, one of whom had a remittance of proteinuria during continued captopril treatment.

MeSH Terms
Adult Aged Basement Membrane/ultrastructure Biopsy Captopril/adverse effects Female Humans Hypertension/drug therapy Hypertension, Renal/drug therapy Hypertension, Renovascular/drug therapy Kidney/drug effects Kidney Glomerulus/ultrastructure Male Middle Aged Proline/analogs & derivatives Proteinuria/chemically induced Time Factors
Chemicals
Proline Captopril
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Case D B
Atlas S A
Mouradian J A
Fishman R A
Sherman R L
Laragh J H
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1980-07-25
Pages
346-9
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com